Ipilimumab vs Semaglutide

## Ipilimumab vs Semaglutide: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Semaglutide**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Semaglutide**: GLP-1 receptor agonist with enhanced albumin binding for extended action.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Semaglutide — 7 days.

## Chemical Properties

**Type**: Ipilimumab — Antibody; Semaglutide — Protein.